학술논문

Arglabin, an EGFR receptor tyrosine kinase inhibitor, suppresses proliferation and induces apoptosis in prostate cancer cells
Document Type
Journal
Source
BIOMEDICINE & PHARMACOTHERAPY; DEC 2022, 156 p113873 12p.
Subject
Language
English
ISSN
19506007